Viewing Study NCT05990192


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2025-12-26 @ 6:42 PM
Study NCT ID: NCT05990192
Status: RECRUITING
Last Update Posted: 2025-04-22
First Post: 2023-06-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Sponsor: Institute of Cancer Research, United Kingdom
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module